Sanisure Acquires MED

Sanisure Acquires MED Sanisure, a leading firm in single-use bioprocessing technology, announced the acquisition of Medical Elastomer Development, Inc. ("MED"), a silicone extrusion facility, from Q Holding, the portfolio company of 3i. The state-of-the-art facility located in Twinsburg, Ohio serves numerous customers among industry leaders in both medical devices and bioprocessing markets. With vertically integrated manufacturing and assembly operations in North America and Europe, Sanisure provides its customers with a broad range of products on a global basis. Sanisure offers Mixed4Sure™ closed-system carboy mixing systems, Cap2v8® solutions, PharmaTainer™ bottles and carboys, aSURE® connectors, Bio-Ease™ tubing clamps, Gamma Mixing Rods and an expanded range of silicone extrusion and carboy products as well as solutions in other elastomeric areas such as Cellgyn® TPE, TPFE, and Kynar tubing. Sanisure CEO Steven Chevillotte stated, "We are excited to have the MED Twinsburg team join Sanisure's growing family. We continue to invest in critical technologies and capabilities that support innovation and provide security for our growing global customer base. Advanced silicone extrusion technology, liquid management products and solutions form the core of our portfolio and enable us to provide our customers with both high-quality silicone tubing and vertically integrated bioprocessing single-use solutions."

3i partner Richard Relyea commented on the acquisition as follows:

"We continue to support Sanisure's strategy through both organic and inorganic growth opportunities. This acquisition will help strengthen our catalog for our key customers working in monoclonal antibodies, vaccines, cell and gene therapy as well as various single-use technology applications."   Source